| Epocrates

By vgreene, 14 October, 2016

DM

By vgreene, 14 October, 2016

CTX

By vgreene, 14 October, 2016

Ca++

By vgreene, 14 October, 2016

BSAP

By vgreene, 14 October, 2016

BMD

By vgreene, 14 October, 2016

Abs

By vgreene, 14 October, 2016

25(OH)D

By vgreene, 14 October, 2016

2°

By vgreene, 14 October, 2016

After 3-5y of initial tx, individualize ongoing tx based on comprehensive risk assessment11 (NOF,9 ASBMR12)

By vgreene, 14 October, 2016

Reassess BMD in all pts q2-3y (NOF,9 ASBMR15)

Stay Connected

Facebook Twitter YouTube